Identifying Cancer Origin Using Circulating Tumor Cells
博士 === 國防醫學院 === 生命科學研究所 === 104 === Circulating tumor cells (CTCs) have become an established clinical evaluation biomarker. CTC count provides a good correlation with the prognosis of cancer patients, but has only been used with known cancer patients, and has been unable to predict the origin of t...
Main Authors: | Lu, Si-Hong, 盧思宏 |
---|---|
Other Authors: | Chang, Ying-Chih |
Format: | Others |
Language: | en_US |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/27772204425613922634 |
Similar Items
-
Heterogeneity of Circulating Tumor Cells in Breast Cancer: Identifying Metastatic Seeds
by: Maxim E. Menyailo, et al.
Published: (2020-03-01) -
Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer
by: Xiumei Zheng, et al.
Published: (2017-06-01) -
Algorithm to identify circulating tumor cell clusters using in vivo flow cytometer
by: Kai Pang, et al.
Published: (2018-09-01) -
Applications of circulating tumor cells for prostate cancer
by: Shirley Cheng, et al.
Published: (2016-10-01) -
Breast cancer circulating tumor cells
by: Maria Joao Carvalho, et al.
Published: (2011-12-01)